WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Stock Ownership - Who owns Novocure?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novocure Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arye Barak BenGeneral Counsel2025-03-0454,975$18.19
$1,000.00kBuy
Christoph BrackmannChief Financial Officer2025-03-0454,975$18.19
$1,000.00kBuy
Frank X. LeonardEVP Pres. Novocure Oncology2025-03-0454,975$18.19
$1,000.00kBuy
Ashley CordovaChief Executive Officer2025-03-04151,181$18.19
$2.75MBuy
Nicolas LeupinChief Medical Officer2025-03-0454,975$18.19
$1,000.00kBuy
Michal Nath PuriChief Human Resources Officer2025-03-0454,975$18.19
$1,000.00kBuy
Mukund ParavasthuChief Operating Officer2025-03-0454,975$18.19
$1,000.00kBuy
URI WeinbergChief Innovation Officer2025-03-0454,975$18.19
$1,000.00kBuy
URI WeinbergChief Innovation Officer2025-03-03268$18.92
$5.07kSell
Mukund ParavasthuChief Operating Officer2025-03-03250$18.54
$4.63kSell

1 of 8

NVCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCR insiders and whales buy or sell their stock.

NVCR Shareholders

What type of owners hold Novocure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William F. Doyle23.14%25,430,468$396.21MInsider
Fmr LLC14.77%16,230,139$252.87MInstitution
Gert L. Perlhagen12.75%14,018,365$218.41MInsider
Blackrock Inc11.85%13,026,498$202.95MInstitution
Vanguard Group Inc10.73%11,796,109$183.78MInstitution
Hansjoerg Wyss8.90%9,780,397$152.38MInsider
Capital International Investors8.07%8,873,902$138.26MInstitution
Volati Ltd6.57%7,216,789$112.44MInsider
Capital World Investors4.38%4,815,529$75.03MInstitution
Pomona Capital VII LP2.49%2,741,925$42.72MInsider

1 of 3

NVCR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCR58.36%41.64%Net BuyingNet Buying
QDEL79.69%20.31%Net SellingNet Selling
UFPT86.07%13.93%Net SellingNet Selling
LIVN90.78%9.22%Net SellingNet Selling
ATEC19.98%80.02%Net SellingNet Selling
View Top Medical Device Stocks

Novocure Stock Ownership FAQ

Who owns Novocure?

Novocure (NASDAQ: NVCR) is owned by 83.28% institutional shareholders, 59.43% Novocure insiders, and 0.00% retail investors. William F. Doyle is the largest individual Novocure shareholder, owning 25.43M shares representing 23.14% of the company. William F. Doyle's Novocure shares are currently valued at $396.21M.

If you're new to stock investing, here's how to buy Novocure stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.